With methamphetamine addiction continuing to skyrocket, the California Dental Hygienists' Association (CDHA) today called on the public to understand that decaying teeth can be one of the first warning signs that a family member or loved one is abusing the drug.

A nationally prominent expert at treating diabetes, a chronic illness with potentially serious complications including blindness, limb amputation and death, said today many complications of diabetes are preventable and family physicians play a key role in preventing and controlling the disease.

The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8; London AIM: PAI) today announces that it has successfully completed a Phase I study with its intravenous sedative/anaesthetic CNS 7056.

Second Sight® Medical Products, Inc., the leading developer of retinal prostheses for the blind, announced that it will increase patient enrollment for the ArgusTM II Retinal Implant study throughout clinical trials sites within Europe.

A novel, patented mosquito-killing technology developed by U.S. Army researchers under a long-term, joint-development agreement between the Walter Reed Army Institute of Research , the United States Army Medical Research and Materiel Command, and the U.S. Army Center for Health Promotion and Preventive Medicine , and targeted at Dengue fever is headed for the field.

Lumen Biomedical, Inc. (Plymouth, MN) announced today that the U.S. Food and Drug Administration (FDA) has cleared its FiberNet® Embolic Protection System (EPS) for the treatment of patients receiving endovascular intervention for carotid artery disease.

PharmaMar has received the Award "Supporting A Cure In Our Time" from the Sarcoma Foundation of America (SFA) for its "support in the search for an effective cure for soft tissue sarcomas," goal of the foundation, during the congress of the Connective Tissue Oncology Society (CTOS) held in London from 13-15 November.

Children's Hospital Boston received a $25 million grant from The Manton Foundation to establish the world's first and only center for research on orphan diseases*.

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from a Phase I study of palifosfamide (ZymafosTM) in combination with doxorubicin at the 14th Annual Connective Tissue Oncology Society (CTOS) meeting held in London, UK, November 13 to 15.

The Wall Street Journal on Tuesday examined how China is increasingly promoting condoms as a method of HIV prevention. While HIV "has long thrived quietly on the fringes of Chinese society" among injection drug users and tainted blood recipients, there is now a risk of HIV spreading further into the general population.